Literature DB >> 1648908

Molecular cloning of a non-isopeptide-selective human endothelin receptor.

Y Ogawa1, K Nakao, H Arai, O Nakagawa, K Hosoda, S Suga, S Nakanishi, H Imura.   

Abstract

We isolated several complementary DNA (cDNA) clones encoding a non-isopeptide-selective human endothelin receptor (ETBR) from a human placenta cDNA library. The clones, different in the length of their 3'-untranslated regions, encoded the same 442-amino acid protein with a transmembrane topology similar to that of other G protein-coupled receptors. The rank order of the binding of ET isopeptides (ET-1, ET-2 and ET-3) to the receptor expressed in COS-7 cells was ET-1 = ET-2 = ET-3. Northern blot analysis identified three mRNA species, 4.3 kb, 2.7 kb and 1.7 kb in size, probably generated by their use of alternative polyadenylation sites. These mRNAs were expressed in a wide variety of human tissues, at the highest level in the brain and at a significant level in cultured endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648908     DOI: 10.1016/0006-291x(91)91806-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Endothelin regulation of neuropeptide release from nerve endings of the posterior pituitary.

Authors:  M F Ritz; E L Stuenkel; G Dayanithi; R Jones; J J Nordmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 2.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 3.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 4.  Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades.

Authors:  M Sokolovsky
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

5.  Regulation of the endothelin system by shear stress in human endothelial cells.

Authors:  H Morawietz; R Talanow; M Szibor; U Rueckschloss; A Schubert; B Bartling; D Darmer; J Holtz
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

6.  [Pathomorphology of coronary atherosclerosis].

Authors:  C Ihling
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

7.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.

Authors:  Luise Holzhauser; Ronald Zolty
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

9.  Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.

Authors:  M G Peter; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.

Authors:  G Rossi; G Albertin; A Belloni; L Zanin; M A Biasolo; T Prayer-Galetti; M Bader; G G Nussdorfer; G Palù; A C Pessina
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.